Tuesday 5 June 2012

Shoulder Joint Injection


Shoulder joint injection

Procedure in Detail:  The patient/family member has been informed of the risks and benefits of the planned procedure.  Informed consent was obtained.

In the fluoroscopy room, the patient was placed in a supine position and the skin over the right shoulder was prepped and draped in a sterile manner.  The joint  was identified on fluoroscopy.  Under fluoroscopic guidance the skin and deeper tissues were numbed  with 0.5% lidocaine.  Under fluoroscopic guidance, a 3½ inch 22 gauge spinal needle was advanced into the cavity of the shoulder joint.  The joint  was injected with a mixture of 4 cc each of 1/8th bupivacaine and 40 mg each of methylprednisolone .

The patient tolerated the procedure well.  The patient’s vital signs were monitored during the procedure.




No comments:

Post a Comment